2026 Regular Session
SB 1724
Makes xylazine a Schedule III controlled substance
In Committee
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Bill overview
SB 1724 - This act makes xylazine a Schedule III controlled substance, except for certain uses described in the act, including manufacturing a drug for an animal or administering the drug to an animal. This act is substantially similar to HB 1881 (2026). SARAH HASKINS
Sponsors
Official sponsors from legislative records.
Primary sponsor
Justin Brown (16)
SenateMO
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours